Table 1.

Laboratory Findings on Admission.

WBC	16,400	/μL	TP	7.1	g/dL	CRP	12.4	mg/dL
Neut	71.9	%	Alb	2.8	g/dL	PCT	0.06	ng/mL
Eosi	4.3	%	AST	50	IU/L	CEA	12.9	ng/mL
Baso	0.7	%	ALT	61	IU/L	SCC	1.2	ng/mL
Ly	16.8	%	LDH	267	IU/L	β-D glucan	<6.0	pg/mL
Mono	6.3	%	ALP	600	IU/L	IgG	1,659	mg/dL
RBC	357×104	/μL	γ-GTP	174	IU/L	IgA	207	mg/dL
Hb	10.7	g/dL	BUN	8	mg/dL	IgM	96	mg/dL
Plt	42.8×104	/μL	Cre	0.4	mg/dL	IgE	860	IU/mL
PT-INR	1.12		T-Bil	0.4	mg/dL	HIV-1,2 antibody	negative
APTT	31.6	s	Na	141	mEq/L	Aspergillus galactomannan antigen	negative
Fib	848.4	mg/dL	Cl	101	mEq/L	Aspergillus precipitating antibody	negative
FDP	10.2	μg/mL	K	4	mEq/L
D-dimer	3.9	μg/mL	Ca	9.1	mg/dL

Alb: albumin, ALP: alkaline phosphatase, ALT: alanine aminotransferase, APTT: activated partial thromboplastin time, AST: aspartate aminotransferase, Baso: basophils, BUN: blood urea nitrogen, Ca: calcium, CEA: carcinoembryonic antigen, Cl: chloride, Cre: creatinine, CRP: C-reactive protein, Eosi: eosinophils, FDP: fibrin degradation products, Fib: fibrinogen, γ-GTP: gamma-glutamyl transpeptidase, Hb: hemoglobin, HIV: human immunodeficiency virus, Ig: immunoglobulin, K: potassium, LDH: lactate dehydrogenase, Ly: lymphocytes, Mono: monocytes, Na: sodium, Neut: neutrophils, PCT: procalcitonin, Plt: platelets, PT-INR: prothrombin time-international normalized ratio, RBC: red blood cells, SCC: squamous cell carcinoma, T-Bil: total bilirubin, TP: total protein, WBC: white blood cells